Soleus Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-252,917
| Closed | -$6.74M | – | 79 |
|
|
2024
Q4 | $6.74M | Sell |
252,917
-409,415
| -62% | -$10.9M | 0.42% | 49 |
|
|
2024
Q3 | $18.9M | Sell |
662,332
-191,296
| -22% | -$5.46M | 1.46% | 21 |
|
|
2024
Q2 | $18.6M | Buy |
853,628
+128,171
| +18% | +$2.79M | 1.64% | 22 |
|
|
2024
Q1 | $16.1M | Buy |
725,457
+699,457
| +2,690% | +$15.5M | 1.19% | 24 |
|
|
2023
Q4 | $561K | Sell |
26,000
-257,500
| -91% | -$5.56M | 0.06% | 66 |
|
|
2023
Q3 | $4.79M | Buy |
+283,500
| New | +$4.79M | 0.44% | 56 |
|
|
2022
Q4 | – | Sell |
-297,840
| Closed | -$7.77M | – | 77 |
|
|
2022
Q3 | $7.77M | Buy |
+297,840
| New | +$7.77M | 1.06% | 29 |
|
|
2020
Q4 | – | Sell |
-6,269
| Closed | -$323K | – | 68 |
|
|
2020
Q3 | $323K | Sell |
6,269
-8,731
| -58% | -$450K | 0.17% | 58 |
|
|
2020
Q2 | $565K | Buy |
+15,000
| New | +$565K | 0.32% | 53 |
|